Drug Trial Radar · NCT07932314
Prognostic Value of Oxygen-15 Water PET in Coronary Artery Disease
Last checked: Nov 20, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
40,000
Planned (sponsor's estimate)
Start
Dec 2026
Primary completion
Dec 2036
Study completion Dec 2036
Sponsor
- Lead sponsor
- Vastra Gotaland RegionGovernment (non-federal)
- Sponsor type
- Government (non-federal)
- Collaborators
- Sahlgrenska University Hospital; Gothia Forum - Center for Clinical Trial
- First posted
- Nov 12, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Diagnostic
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study evaluates the prognostic value of quantitative myocardial perfusion imaging using oxygen-15 water positron emission tomography in patients with clinically suspected or known coronary artery disease (main basket), and explores temporal changes in myocardial perfusion related to disease progression, underlying pathophysiological processes, or treatment-related effects (additional baskets).
Conditions
- Coronary Artery Disease
- Microvascular Coronary Artery Disease
- Microvascular Coronary Dysfunction
Interventions
Oxygen-15 WaterDrug
Oxygen-15 water enables absolute quantification of myocardial blood flow at rest and during pharmacological stress using PET. In the main basket, participants will undergo a single quantitative myocardial perfusion imaging examination using oxygen-15 water PET at rest and during pharmacological stress (adenosine or regadenoson). In the additional baskets, the same examination will be performed twice, at baseline and at follow-up. In all baskets, blood samples will be collected when feasible and stored in a biobank for future research.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Prognostic Thresholds of Stress Myocardial Blood Flow for Predicting MACE-1 (Main Basket)Time frame: 2 and 5 years after the PET examination
- Prognostic Thresholds of Rest Myocardial Blood Flow for Predicting MACE-1 (Main Basket)Time frame: 2 and 5 years after the PET examination
- Prognostic Thresholds of Myocardial Flow Reserve for Predicting MACE-1 (Main Basket)Time frame: 2 and 5 years after the PET examination
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Department of Clinical Physiology, Sahlgrenska University Hospital
Gothenburg, Sweden · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.